Elevance Health (ELV) Revenue & Revenue Breakdown
Elevance Health Revenue Highlights
Latest Revenue (Y)
$171.34B
Latest Revenue (Q)
$45.15B
Main Segment (Y)
Health Benefits Segment
Elevance Health Revenue by Period
Elevance Health Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $171.34B | 9.42% |
2022-12-31 | $156.59B | 12.95% |
2021-12-31 | $138.64B | 13.76% |
2020-12-31 | $121.87B | 16.94% |
2019-12-31 | $104.21B | 13.15% |
2018-12-31 | $92.11B | 2.29% |
2017-12-31 | $90.04B | 5.96% |
2016-12-31 | $84.98B | 7.24% |
2015-12-31 | $79.24B | 7.19% |
2014-12-31 | $73.92B | 3.94% |
2013-12-31 | $71.12B | 15.58% |
2012-12-31 | $61.53B | 1.20% |
2011-12-31 | $60.80B | 3.34% |
2010-12-31 | $58.84B | -4.55% |
2009-12-31 | $61.64B | - |
Elevance Health Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | $45.15B | 3.43% |
2024-06-30 | $43.65B | 2.51% |
2024-03-31 | $42.58B | -0.16% |
2023-12-31 | $42.65B | -0.47% |
2023-09-30 | $42.85B | -1.88% |
2023-06-30 | $43.67B | 3.56% |
2023-03-31 | $42.17B | 5.62% |
2022-12-31 | $39.93B | -0.03% |
2022-09-30 | $39.94B | 3.38% |
2022-06-30 | $38.63B | 1.41% |
2022-03-31 | $38.09B | 4.14% |
2021-12-31 | $36.58B | 2.12% |
2021-09-30 | $35.82B | 5.82% |
2021-06-30 | $33.85B | 4.53% |
2021-03-31 | $32.38B | 1.76% |
2020-12-31 | $31.82B | 2.14% |
2020-09-30 | $31.16B | 6.47% |
2020-06-30 | $29.26B | -1.21% |
2020-03-31 | $29.62B | 8.08% |
2019-12-31 | $27.41B | 2.75% |
2019-09-30 | $26.67B | 4.74% |
2019-06-30 | $25.47B | 3.24% |
2019-03-31 | $24.67B | 5.53% |
2018-12-31 | $23.37B | 0.52% |
2018-09-30 | $23.25B | 1.34% |
2018-06-30 | $22.94B | 1.80% |
2018-03-31 | $22.54B | -0.63% |
2017-12-31 | $22.68B | 1.13% |
2017-09-30 | $22.43B | 0.08% |
2017-06-30 | $22.41B | -0.53% |
2017-03-31 | $22.53B | 3.68% |
2016-12-31 | $21.73B | 1.45% |
2016-09-30 | $21.41B | -0.19% |
2016-06-30 | $21.46B | 5.76% |
2016-03-31 | $20.29B | 0.50% |
2015-12-31 | $20.19B | 1.44% |
2015-09-30 | $19.90B | -0.57% |
2015-06-30 | $20.02B | 5.06% |
2015-03-31 | $19.05B | 0.35% |
2014-12-31 | $18.98B | 2.30% |
2014-09-30 | $18.56B | 0.45% |
2014-06-30 | $18.47B | 3.44% |
2014-03-31 | $17.86B | 1.64% |
2013-12-31 | $17.57B | -2.22% |
2013-09-30 | $17.97B | 0.98% |
2013-06-30 | $17.80B | 0.61% |
2013-03-31 | $17.69B | 13.85% |
2012-12-31 | $15.54B | 1.19% |
2012-09-30 | $15.35B | -0.35% |
2012-06-30 | $15.41B | -0.05% |
2012-03-31 | $15.42B | 0.64% |
2011-12-31 | $15.32B | -0.52% |
2011-09-30 | $15.40B | 1.97% |
2011-06-30 | $15.10B | 1.39% |
2011-03-31 | $14.89B | 1.68% |
2010-12-31 | $14.65B | 0.34% |
2010-09-30 | $14.60B | 0.98% |
2010-06-30 | $14.46B | -4.25% |
2010-03-31 | $15.10B | -20.73% |
2009-12-31 | $19.05B | - |
Elevance Health Revenue Breakdown
Elevance Health Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|---|---|
Health Benefits Segment | $148.57B | - | - | - | - |
Other Segment | $479.00M | $13.29B | $10.25B | $2.15B | $3.09B |
Segment Eliminations | $-340.00M | $-24.64B | $-20.47B | - | - |
Carelon Services Segment | $95.96B | - | - | - | - |
IngenioRx Segment | - | $14.97B | $12.78B | $10.38B | - |
Government Business Segment | - | $96.81B | $82.92B | $71.57B | - |
Commercial Specialty Business Segment | - | $41.67B | $38.81B | $36.70B | - |
Latest
Quarterly Revenue by Product
Product/Service | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Health Benefits Segment | $38.28B | $37.16B | $37.26B | $36.55B | $36.74B | $38.00B | $37.28B | - | - | - | - | - | - | - | - | - | - | - | - | - |
Carelon Services Segment | $27.56B | $26.64B | $24.15B | $25.69B | $23.78B | $23.81B | $22.67B | - | - | - | - | - | - | - | - | - | - | - | - | - |
Other Segment | - | - | - | - | $242.00M | $326.00M | $251.00M | $3.41B | $3.37B | $3.30B | $3.22B | $2.69B | $2.67B | $2.52B | $2.37B | - | $624.00M | $603.00M | $1.03B | - |
Segment Eliminations | - | - | - | - | $-97.00M | $-73.00M | $-76.00M | - | $-6.05B | $-6.28B | $-6.04B | - | $-5.19B | $-5.07B | $-4.91B | $-3.60B | - | - | - | - |
Government Business Segment | - | - | - | - | - | - | - | $24.65B | $24.57B | $23.84B | $23.76B | $21.91B | $21.66B | $20.07B | $19.28B | $54.11B | $17.47B | - | - | - |
Commercial Specialty Business Segment | - | - | - | - | - | - | - | $10.35B | $10.49B | $10.56B | $10.27B | $9.90B | $9.86B | $9.55B | $9.49B | $9.22B | $9.36B | - | - | - |
IngenioRx Segment | - | - | - | - | - | - | - | - | $7.25B | $7.07B | $6.68B | - | $6.55B | $6.22B | $5.86B | $45.00M | $2.60B | $2.54B | $5.20B | - |
Commercial Specialty | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $9.33B | $8.79B | - | - |
Latest